Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0083 Transporter Info | ||||
Gene Name | SLC12A2 | ||||
Transporter Name | Basolateral Na-K-Cl symporter | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
JUN |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC12A2 gene in coronary artery disease condition | [1] | ||||
TF Protein Name |
Transcription factor Jun | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor Jun (JUN) has been reported to bind to the transcription of SLC12A2 gene in coronary artery disease condition, which leads to an affected expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
JUND |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC12A2 gene in coronary artery disease condition | [1] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor JunD (JUND) has been reported to bind to the transcription of SLC12A2 gene in coronary artery disease condition, which leads to an affected expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
ARNT |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [2] | ||||
TF Protein Name |
Aryl hydrocarbon receptor nuclear translocator | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Aryl hydrocarbon receptor nuclear translocator (ARNT) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
BHLHE40 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [3] | ||||
TF Protein Name |
Class E basic helix-loop-helix protein 40 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Class E basic helix-loop-helix protein 40 (BHLHE40) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
MYOD1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [4] | ||||
TF Protein Name |
Myoblast determination protein 1 | Transcription Factor Info | ||||
Tissue |
Myotube | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myoblast determination protein 1 (MYOD1) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
TCF12 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [5] | ||||
TF Protein Name |
Transcription factor 12 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor 12 (TCF12) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [2] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
TCF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC12A2 gene in glioblastoma multiforme condition | [6] | ||||
TF Protein Name |
Transcription factor 4 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Temozolomide | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 4 (TCF4) has been reported to bind to the transcription of SLC12A2 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GATA4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC12A2 gene in gastric cancer condition | [7] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Metformin | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) has been reported to activate the transcription of SLC12A2 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 10 TF(s) Regulating This DT |
|||||
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [5] | ||||
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
Tissue |
Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
CTCFL |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [5] | ||||
TF Protein Name |
Transcriptional repressor CTCFL | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCFL (CTCFL) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC12A2 gene in erythroleukemia condition | [8] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Early growth response protein 1 (EGR1) has been reported to bind to the transcription of SLC12A2 gene in erythroleukemia condition, which leads to an affected expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
KLF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [2] | ||||
TF Protein Name |
Krueppel-like factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 1 (KLF1) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [2] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Tissue |
Embryo; Pancreatic ductal; Stomach | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [4] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
SALL4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC12A2 gene in health condition | [9] | ||||
TF Protein Name |
Sal-like protein 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Sal-like protein 4 (SALL4) has been reported to bind to the transcription of SLC12A2 gene in health condition, which leads to an affected expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
WT1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC12A2 gene in podocyte condition | [10] | ||||
TF Protein Name |
Wilms tumor protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Wilms tumor protein (WT1) has been reported to activate the transcription of SLC12A2 gene in podocyte condition, which leads to an increased expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
YY1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [3] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Colon; Embryo; Liver; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor protein YY1 (YY1) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [4] | ||||
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
CDX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene in health condition | [11] | ||||
TF Protein Name |
Homeobox protein CDX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Homeobox protein CDX-2 (CDX2) has been reported to bind to the transcription of SLC12A2 gene in health condition, which leads to an affected expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
HOXB13 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [2] | ||||
TF Protein Name |
Homeobox protein Hox-B13 | Transcription Factor Info | ||||
Tissue |
Colon; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Homeobox protein Hox-B13 (HOXB13) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
ZEB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [2] | ||||
TF Protein Name |
Zinc finger E-box-binding homeobox 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger E-box-binding homeobox 1 (ZEB1) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
E2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [4] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Tissue |
Mesenchymal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [3] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Cervix; Embryo; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [3] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Tissue |
Embryo; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
ERG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [5] | ||||
TF Protein Name |
Transcriptional regulator ERG | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional regulator ERG (ERG) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [2] | ||||
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Kidney; Lung; Prostate; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [4] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [5] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Breast; Cervix; Embryo; Liver; Lung; Mesenchymal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
IRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [3] | ||||
TF Protein Name |
Interferon regulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Pancreatic ductal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 1 (IRF1) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
MYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [5] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
SPI1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC12A2 gene in APL condition | [12] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) has been reported to bind to the transcription of SLC12A2 gene in acute promyelocytic leukemia (APL) condition, which leads to an affected expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC12A2 gene | [3] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Adrenal gland; Blood; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
Class3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
KDM5B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [4] | ||||
TF Protein Name |
Lysine-specific demethylase 5B | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Lysine-specific demethylase 5B (KDM5B) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
Class4.1: High-mobility group domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SOX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC12A2 gene in colorectal cancer condition | [13] | ||||
TF Protein Name |
Transcription factor SOX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor SOX-2 (SOX2) has been reported to activate the transcription of SLC12A2 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
Class5.1: MADS box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SRF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC12A2 gene | [5] | ||||
TF Protein Name |
Serum response factor | Transcription Factor Info | ||||
Tissue |
Embryo; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Serum response factor (SRF) can directly bind to the SLC12A2 gene, which in turn affects the expression or function of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TP53 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC12A2 gene in HFKS condition | [14] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to bind to the transcription of SLC12A2 gene in HFKS condition, which leads to an affected expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
Transcriptional Phenomenon2 |
Binding to SLC12A2 gene in health condition | [15] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to bind to the transcription of SLC12A2 gene in health condition, which leads to an affected expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC12A2 gene in epithelial ovarian cancer condition | [16] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to bind to the transcription of SLC12A2 gene in epithelial ovarian cancer condition, which leads to an affected expression of the drug transporter Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.